###
中国临床研究:2026,39(10):1599-1604
本文二维码信息
码上扫一扫!
GNPTAB基因突变致黏脂贮积症Ⅱα/β型1例及其酶学分析
(1. 中国人民解放军联勤保障部队第980医院新生儿科,河北 石家庄 050083;2. 中国人民解放军联勤保障部队第980医院神经内科,河北 石家庄 050083)
A case of mucolipidosis Ⅱalpha/beta caused by GNPTAB gene mutation and its enzyme analysis
摘要
本文已被:浏览 136次   下载 238次
投稿时间:2026-04-22   网络发布日期:2026-10-23
中文摘要: 目的  总结N-乙酰葡糖胺-1-磷酸转移酶α和β亚基(GNPTAB)基因复合杂合突变导致的新生儿黏脂贮积症(ML)Ⅱα/β型的临床特征、酶学与基因诊断方法,阐明其病理生理机制与表型关系。方法  回顾性分析1 例MLⅡα/β型患儿的临床资料,行全外显子组测序检测发现GNPTAB 基因变异,并采用荧光底物法测定外周血白细胞及血浆中多种溶酶体酶活性。结果  患儿出生即表现为特殊面容、骨骼畸形、肌张力低下等典型特征。基因检测提示GNPTAB基因存在c.2404C>T(父源)与c.289A>T(母源,新发)两个无义突变。酶学检测显示白细胞内β-半乳糖苷酶及β-葡萄糖醛酸苷酶活性降低,血浆中总氨基己糖苷酶及β-葡萄糖醛酸苷酶活性显著升高。随访中患儿逐渐出现生长迟缓、心脏缺损、关节挛缩及神经发育落后。结论  MLⅡα/β型为GNPTAB基因突变所致溶酶体酶M6P标记缺陷疾病,推荐将白细胞内β-半乳糖苷酶、β-葡萄糖醛酸苷酶以及血浆中总氨基己糖苷酶、β-葡萄糖醛酸苷酶作为MLⅡα/β型和MLⅢα/β型酶学检测指标。建议临床联合酶学与基因检测以实现早期诊断与鉴别。
Abstract:Objective To summarize the clinical features,enzymatic and genetic diagnostic approaches in a neonatal case of mucolipidosis(ML)Ⅱα/β caused by compound heterozygous mutations in the N-acetylglucosamine - 1 -phosphatetransferase subunits alpha and beta (GNPTAB)gene,and to elucidate the relationship between its pathophysiology and phenotype. Methods Clinical data of a neonate with ML Ⅱα/β were retrospectively reviewed.Whole-exome sequencing was performed to identify GNPTAB gene variants,and various lysosomal enzymes activities in peripheral blood leukocytes and plasma were measured using fluorogenic substrate assay. Results The neonate exhibited typical manifestations at birth,including distinctive facies,skeletal abnormalities and hypotonia. Genetic analysis identified two nonsense mutations in GNPTAB:c.2404C>T(paternally inherited)and c.289A>T(maternally inherited,de novo). Enzyme activity profiles demonstrated a characteristic with reduced β - galactosidase and β -glucuronidase in leukocytes and markedly elevated total hexosaminidase and β-glucuronidase in plasma. During follow-up,progressive growth retardation,cardiac defects,joint contractures,and neurodevelopmental delay were observed.Conclusion ML Ⅱα/β type is a lysosomal enzyme M6P tagging defect disease caused by GNPTAB gene mutations. It is recommended that β - galactosidase and β - glucuronidase in leukocytes,as well as total hexosaminidase and β -glucuronidase in plasma,be adopted as enzymatic biomarkers for the biochemical testing of MLⅡα/β and MLⅢα/β.Combined enzymatic assay and genetic testing is advised in clinical practice to facilitate early diagnosis and differential diagnosis.
文章编号:     中图分类号:R722.1    文献标志码:B
基金项目:石家庄市科技计划项目(221460473)
附件
引用文本:
梁如佳,刘芳,阴晓伟,等.GNPTAB基因突变致黏脂贮积症Ⅱα/β型1例及其酶学分析[J].中国临床研究,2026,39(10):1599-1604.

用微信扫一扫

用微信扫一扫